摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-phenyl-quinoline-4-carbonyl chloride ; hydrochloride | 7187-80-6

中文名称
——
中文别名
——
英文名称
2-phenyl-quinoline-4-carbonyl chloride ; hydrochloride
英文别名
2-Phenyl-chinolin-4-carbonylchlorid; Hydrochlorid;2-phenylquinoline-4-carboxylic acid chloride hydrochloride;2-Phenylquinoline-4-carbonyl chloride hydrochloride;2-phenylquinoline-4-carbonyl chloride;hydrochloride
2-phenyl-quinoline-4-carbonyl chloride ; hydrochloride化学式
CAS
7187-80-6
化学式
C16H10ClNO*ClH
mdl
——
分子量
304.175
InChiKey
MHADDXHZPKUFBY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    120~123℃

计算性质

  • 辛醇/水分配系数(LogP):
    4.7
  • 重原子数:
    20
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    30
  • 氢给体数:
    1
  • 氢受体数:
    2

安全信息

  • 危险等级:
    IRRITANT

反应信息

点击查看最新优质反应信息

文献信息

  • Pharmaceutical compositions containing naphthalene-and
    申请人:Rhone-Poulenc Sante
    公开号:US04684652A1
    公开(公告)日:1987-08-04
    Compounds of the formula: ##STR1## in which R.sub.1 is C.sub.1-6 alkyl, phenyl, C.sub.3-6 cycloalkyl, phenylalkyl, cycloalkyl-alkyl or ##STR2## R.sub.3 and R.sub.4 being H or alkyl, R.sub.5 being alkenyl or alkynyl, and the sum of the carbon atoms in R.sub.3, R.sub.4 and R.sub.5 being 2 to 5, R.sub.2 is as defined for R.sub.1 and may also represent ##STR3## in which n is 0, 1, 2 or 3, it also being possible for R.sub.1 and R.sub.2 to form, with the nitrogen atom to which they are attached, a 5-, 6- or 7-membered heterocyclic radical which can contain another hetero-atom chosen from O and N and which can carry 1 or 2 substituents, Z is phenyl, pyridinyl, thienyl, thiazol-2-yl or substituted phenyl, X and R.sub.0 are H, halogen, C.sub.1-3 alkyl, C.sub.1-3 alkoxy, nitro or CF.sub.3, A represents N or CH and E represents N or CH, some of which are known compounds, are therapeutically useful compounds useful in the treatment of anxiety states or of pulmonary, renal, circulatory or cardiovascular disorders.
    公式中的化合物:##STR1## 其中R.sub.1是C.sub.1-6烷基,苯基,C.sub.3-6环烷基,苯基烷基,环烷基-烷基或##STR2## R.sub.3和R.sub.4为H或烷基,R.sub.5为烯基或炔基,且R.sub.3,R.sub.4和R.sub.5中碳原子的总和为2至5,R.sub.2的定义与R.sub.1相同,也可以表示为##STR3## 其中n为0、1、2或3,R.sub.1和R.sub.2也可以与它们所连接的氮原子形成一个5-、6-或7-成员的杂环基团,该杂环基团可以含有另一个来自O和N的杂原子,并且可以携带1个或2个取代基,Z是苯基,吡啶基,噻吩基,噻唑-2-基或取代的苯基,X和R.sub.0是H,卤素,C.sub.1-3烷基,C.sub.1-3烷氧基,硝基或CF.sub.3,A代表N或CH,E代表N或CH,其中一些是已知的化合物,是有治疗焦虑状态或肺、肾、循环或心血管障碍的药用化合物。
  • Pharmaceutical compositions containing azanaphthalene-carboxamide
    申请人:Rhone-Poulenc Sante
    公开号:US04711890A1
    公开(公告)日:1987-12-08
    Compounds of the formula: ##STR1## in which R.sub.1 is C.sub.1-6 alkyl, phenyl, C.sub.3-6 cycloalkyl, phenylalkyl, cycloalkyl-alkyl or ##STR2## R.sub.3 and R.sub.4 being H or alkyl, R.sub.5 being alkenyl or alkynyl, and the sum of the carbon atoms in R.sub.3, R.sub.4 and R.sub.5 being 2 to 5, R.sub.2 is as defined for R.sub.1 and may also represent ##STR3## in which n is 0, 1, 2 or 3, it also being possible for R.sub.1 and R.sub.2 to form, with the nitrogen atom to which they are attached, a 5-, 6- or 7-membered heterocyclic radical which can contain another hetero-atom chosen from O and N and which can carry 1 or 2 substituents, Z is phenyl, pyridinyl, thienyl, thiazol-2-yl or substituted phenyl, X and R.sub.0 are H, halogen, C.sub.1-3 alkyl, C.sub.1-3 alkoxy, nitro or CF.sub.3, A represents N or CH and E represents N or CH, some of which are known compounds, are therapeutically useful compounds useful in the treatment of anxiety states or of pulmonary, renal, circulatory or cardiovascular disorders.
    这个化合物的式子为:##STR1## 其中R.sub.1是C.sub.1-6烷基,苯基,C.sub.3-6环烷基,苯基烷基,环烷基-烷基或##STR2## R.sub.3和R.sub.4为H或烷基,R.sub.5为烯基或炔基,且R.sub.3,R.sub.4和R.sub.5中的碳原子总数为2到5,R.sub.2与R.sub.1的定义相同,也可以表示为##STR3## 其中n为0,1,2或3,R.sub.1和R.sub.2也可以与它们附着的氮原子形成一个5、6或7成员的杂环基团,该杂环基团可以含有另一个从O和N中选择的杂原子,并且可以携带1或2个取代基,Z为苯基,吡啶基,噻吩基,噻唑-2-基或取代苯基,X和R.sub.0为H,卤素,C.sub.1-3烷基,C.sub.1-3烷氧基,硝基或CF.sub.3,A代表N或CH,E代表N或CH,其中一些已知化合物,在治疗焦虑症或肺部,肾脏,循环或心血管疾病方面有用。
  • DE252643
    申请人:——
    公开号:——
    公开(公告)日:——
  • Rojahn; Schulten, Archiv der Pharmazie, 1926, p. 350
    作者:Rojahn、Schulten
    DOI:——
    日期:——
  • US4684652A
    申请人:——
    公开号:US4684652A
    公开(公告)日:1987-08-04
查看更多